Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myfortic vs Mycophenolate Mofetil in multi-system autoimmune disease
2005-002207-16Phase 2Completed
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of mycophenolate sodium and mycophenolate mofetil in vasculitis and systemic lupus erythematosus (SLE) (2 arms), sponsored by Cambridge University Hospitals NHS Foundation Trust. Primary endpoint: Therapeutic failure at six months. Started Aug 2005; status: completed.
02
Drugs
mycophenolate sodiummycophenolate mofetil
03
Conditions
vasculitissystemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on 2005-002207-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002207-16.